Most Recent
Mayne Pharma has said it may seek to shut out US drug maker Cosette's expert evidence in proceedings over the purported termination of their $672 million merger.
A discrimination class action has been filed on behalf of single women and same-sex couples designated "socially infertile" and denied Medicare rebates for IVF.
Flu vaccine maker Seqirus has successfully opposed Moderna’s proposed patent for a mRNA vaccine, but an IP Australia delegate said the problems with the patent can be overcome by amendments.
US biotech company Regeneron Pharmaceuticals has sued Sandoz, claiming it is threatening to infringe the patent for its Eylea biologic, used to treat macular degeneration and diabetic macular oedema.
Private health insurer Bupa has admitted to misleading thousands of customers about their private health insurance benefits and has agreed to cop a $35 million penalty in a case by the consumer watchdog.
The Therapeutic Goods Administration has dragged Mamamia and News Corp-owned Body + Soul magazine to Federal Court over alleged unlawful medicinal cannabis advertising.
Monash IVF has won an injunction against its former chief operating officer, who departed after the fertility company's embryo mix-up came to light, that limits his participation in his new employer's Australian operations.
A judge has sent to the Full Federal Court Medibank’s fight to shield Deloitte reports into a data breach, raising concerns about how evidence from a solicitor and the health insurer's inhouse lawyer was previously treated.
Mayne Pharma has said it will file a court challenge to the validity of US drug maker Cosette Pharmaceuticals' purported termination of a $672 million takeover offer.
The Therapeutic Goods Administration has launched legal action against Philips Electronics for allegedly supplying CPAP and BiPAP devices, used to assist individuals with sleep apnea, which it knew posed risks to users.